DZ3163A1 - Nouvelle substance pharmaceutique. - Google Patents

Nouvelle substance pharmaceutique.

Info

Publication number
DZ3163A1
DZ3163A1 DZ003163A DZ003163A DZ3163A1 DZ 3163 A1 DZ3163 A1 DZ 3163A1 DZ 003163 A DZ003163 A DZ 003163A DZ 003163 A DZ003163 A DZ 003163A DZ 3163 A1 DZ3163 A1 DZ 3163A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical substance
new pharmaceutical
new
substance
pharmaceutical
Prior art date
Application number
DZ003163A
Other languages
English (en)
French (fr)
Inventor
Paul David James Blackler
Robert Gordon Giles
Michael John Sasse
Andrew Simon Graig
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DZ3163A1 publication Critical patent/DZ3163A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DZ003163A 1999-04-20 2000-04-19 Nouvelle substance pharmaceutique. DZ3163A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909075.5A GB9909075D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical
PCT/GB2000/001527 WO2000063206A2 (en) 1999-04-20 2000-04-19 Thiazolidinedione derivative and its use as antidiabetic

Publications (1)

Publication Number Publication Date
DZ3163A1 true DZ3163A1 (fr) 2000-10-26

Family

ID=10851922

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ003163A DZ3163A1 (fr) 1999-04-20 2000-04-19 Nouvelle substance pharmaceutique.

Country Status (42)

Country Link
EP (2) EP1411054A1 (cs)
JP (2) JP4283450B2 (cs)
KR (1) KR100677815B1 (cs)
CN (2) CN101125851A (cs)
AP (1) AP1680A (cs)
AR (2) AR023563A1 (cs)
AT (1) ATE262524T1 (cs)
AU (1) AU773112B2 (cs)
BG (1) BG65428B1 (cs)
BR (1) BR0009898A (cs)
CA (1) CA2370270A1 (cs)
CO (1) CO5170420A1 (cs)
CZ (1) CZ300934B6 (cs)
DE (1) DE60009276T2 (cs)
DK (1) DK1173437T3 (cs)
DZ (1) DZ3163A1 (cs)
EA (1) EA004769B1 (cs)
EG (1) EG23946A (cs)
ES (1) ES2214267T3 (cs)
GB (1) GB9909075D0 (cs)
HK (1) HK1045304B (cs)
HR (1) HRP20010771B1 (cs)
HU (1) HUP0200785A3 (cs)
IL (1) IL146077A0 (cs)
MA (1) MA26784A1 (cs)
MX (1) MXPA01010695A (cs)
MY (1) MY125209A (cs)
NO (1) NO320573B1 (cs)
NZ (1) NZ515164A (cs)
OA (1) OA11867A (cs)
PE (1) PE20010047A1 (cs)
PL (1) PL351115A1 (cs)
PT (1) PT1173437E (cs)
RS (1) RS50137B (cs)
SI (1) SI1173437T1 (cs)
SK (1) SK284990B6 (cs)
TR (1) TR200103041T2 (cs)
TW (1) TWI291463B (cs)
UA (1) UA72245C2 (cs)
UY (1) UY26113A1 (cs)
WO (1) WO2000063206A2 (cs)
ZA (1) ZA200108721B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
KR20040062963A (ko) * 2001-11-21 2004-07-09 스미스클라인비이참피이엘시이 5-(4-(2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시)벤질)티아졸리딘-2,4-디온 벤젠술포네이트, 그의 제조 방법, 그의다형체 ⅰ, ⅱ 및 ⅲ, 및 제약상 활성 성분으로서의 그의용도
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
US20050105328A1 (en) * 2003-11-17 2005-05-19 Ho Chiahua Perpendicular MRAM with high magnetic transition and low programming current
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
BG106120A (en) 2002-05-31
UY26113A1 (es) 2000-12-29
SK284990B6 (sk) 2006-04-06
CZ300934B6 (cs) 2009-09-16
HK1045304A1 (en) 2002-11-22
WO2000063206A2 (en) 2000-10-26
TWI291463B (en) 2007-12-21
JP2002542243A (ja) 2002-12-10
HRP20010771B1 (en) 2005-06-30
HUP0200785A2 (en) 2002-08-28
UA72245C2 (uk) 2005-02-15
ES2214267T3 (es) 2004-09-16
JP2009161544A (ja) 2009-07-23
EA200101102A1 (ru) 2002-04-25
ZA200108721B (en) 2002-09-13
TR200103041T2 (tr) 2002-03-21
NO320573B1 (no) 2005-12-27
PL351115A1 (en) 2003-03-24
CZ20013758A3 (cs) 2003-05-14
MA26784A1 (fr) 2004-12-20
PT1173437E (pt) 2004-06-30
JP4283450B2 (ja) 2009-06-24
KR100677815B1 (ko) 2007-02-05
OA11867A (en) 2006-03-02
DK1173437T3 (da) 2004-07-12
PE20010047A1 (es) 2001-03-10
IL146077A0 (en) 2002-07-25
AP2001002332A0 (en) 2001-12-31
ATE262524T1 (de) 2004-04-15
GB9909075D0 (en) 1999-06-16
HK1045304B (en) 2004-12-24
CA2370270A1 (en) 2000-10-26
EP1173437A2 (en) 2002-01-23
RS50137B (sr) 2009-03-25
DE60009276T2 (de) 2004-08-26
CN101125851A (zh) 2008-02-20
YU81601A (sh) 2004-09-03
SK14892001A3 (sk) 2002-02-05
WO2000063206A3 (en) 2001-02-22
KR20010112446A (ko) 2001-12-20
NZ515164A (en) 2004-02-27
AR023567A1 (es) 2002-09-04
MY125209A (en) 2006-07-31
HUP0200785A3 (en) 2004-03-29
CO5170420A1 (es) 2002-06-27
NO20015105D0 (no) 2001-10-19
MXPA01010695A (es) 2002-06-04
DE60009276D1 (de) 2004-04-29
EA004769B1 (ru) 2004-08-26
EP1173437B1 (en) 2004-03-24
EG23946A (en) 2008-01-22
CN1327446A (zh) 2001-12-19
AP1680A (en) 2006-11-27
AR023563A1 (es) 2002-09-04
NO20015105L (no) 2001-12-19
HRP20010771A2 (en) 2002-12-31
AU4131100A (en) 2000-11-02
SI1173437T1 (en) 2004-06-30
BR0009898A (pt) 2002-04-16
AU773112B2 (en) 2004-05-20
BG65428B1 (bg) 2008-07-31
EP1411054A1 (en) 2004-04-21

Similar Documents

Publication Publication Date Title
MA26937A1 (fr) Nouvelle composition pharmaceutique.
MA26497A1 (fr) Nouvelle formulation pharmaceutique
FI991485L (fi) Uusi farmaseuttinen koostumus
TR199901077A3 (tr) Ispençiyari formülasyonlar.
DZ3155A1 (fr) Nouvelle composition pharmaceutique.
NO20015175L (no) Farmasöytisk sammensetning
DZ1966A1 (fr) Combinaison pharmaceutique nouvelle.
DZ2516A1 (fr) Composition pharmaceutique en aérosol.
NO20020304D0 (no) Konserverte farmasöytiske preparater
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
NO20020086D0 (no) Smaksmaskerte farmasöytiske flytende formuleringer
TR199802624A3 (tr) Yeni farmasötik.
PT1210085E (pt) Solucoes farmaceuticas de levosimendano
DK1275397T3 (da) Lægemiddel til lokal anvendelse
NO20022606L (no) Farmasöytiske kombinasjoner
DZ3164A1 (fr) Nouvel agent pharmaceutique.
ID27150A (id) Sediaan levotiroksin bahan farmasi
NO20014926D0 (no) Farmasöytiske forbindelser
DZ3163A1 (fr) Nouvelle substance pharmaceutique.
NO20021866D0 (no) Ciclesonid-inneholdende vandig farmasöytisk blanding
MA26531A1 (fr) Composition pharmaceutique
FI4488U1 (fi) Farmaseuttinen koostumus
DZ3162A1 (fr) Nouveau composé pharmaceutique.
AR025867A1 (es) Formulacion portasdora farmaceutica
MA26801A1 (fr) Complexe pharmaceutique